These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 8761368)
21. Combination cytotoxic-differentiation therapy of mouse erythroleukemia cells with 5-fluorouracil and hexamethylene bisacetamide. Waxman S; Scher BM; Hellinger N; Scher W Cancer Res; 1990 Jul; 50(13):3878-87. PubMed ID: 2354439 [TBL] [Abstract][Full Text] [Related]
22. Induction of squamous differentiation by interferon beta in a human non-small-cell lung cancer cell line. Nair S; Mayotte J; Lokshin A; Levitt M J Natl Cancer Inst; 1994 Mar; 86(5):378-83. PubMed ID: 7905929 [TBL] [Abstract][Full Text] [Related]
23. Interferon and retinoic acid suppress the growth of human papillomavirus type 16 immortalized cervical epithelial cells, but only interferon suppresses the level of the human papillomavirus transforming oncogenes. Agarwal C; Hembree JR; Rorke EA; Eckert RL Cancer Res; 1994 Apr; 54(8):2108-12. PubMed ID: 8174114 [TBL] [Abstract][Full Text] [Related]
24. Free interferon-alpha/beta receptors in the circulation of patients with adenocarcinoma. Ambrus JL; Dembinski W; Ambrus JL; Sykes DE; Akhter S; Kulaylat MN; Islam A; Chadha KC Cancer; 2003 Dec; 98(12):2730-3. PubMed ID: 14669296 [TBL] [Abstract][Full Text] [Related]
25. Differentiation of BCS-TC2 human colon adenocarcinoma cells by sodium butyrate: increase in 5'-nucleotidase activity. Navarro JM; Olmo N; Turnay J; López-Conejo MT; Lizarbe MA Eur J Clin Invest; 1997 Jul; 27(7):620-8. PubMed ID: 9263751 [TBL] [Abstract][Full Text] [Related]
26. Effects of sodium butyrate and dimethylsulfoxide on human pancreatic tumor cell lines. McIntyre LJ; Kim YS Eur J Cancer Clin Oncol; 1984 Feb; 20(2):265-71. PubMed ID: 6200329 [TBL] [Abstract][Full Text] [Related]
27. Sodium butyrate alters the response of a human colon carcinoma cell line to transforming growth factor-beta 1. Lewis LR; Levine AE Cancer Lett; 1992 Mar; 63(1):33-40. PubMed ID: 1555205 [TBL] [Abstract][Full Text] [Related]
28. Biologic and binding activities of IFN-alpha subtypes in ACHN human renal cell carcinoma cells and Daudi Burkitt's lymphoma cells. Yamaoka T; Kojima S; Ichi S; Kashiwazaki Y; Koide T; Sokawa Y J Interferon Cytokine Res; 1999 Dec; 19(12):1343-9. PubMed ID: 10638703 [TBL] [Abstract][Full Text] [Related]
29. Sodium butyrate enhances STAT 1 expression in PLC/PRF/5 hepatoma cells and augments their responsiveness to interferon-alpha. Hung WC; Chuang LY Br J Cancer; 1999 May; 80(5-6):705-10. PubMed ID: 10360647 [TBL] [Abstract][Full Text] [Related]
30. Antiproliferative effects of 5-fluorouracil and interferon-alpha in combination on a hepatocellular carcinoma cell line in vitro and in vivo. Kojiro S; Yano H; Ogasawara S; Momosaki S; Takemoto Y; Nishida N; Kojiro M J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):129-37. PubMed ID: 16706824 [TBL] [Abstract][Full Text] [Related]
31. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells. Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668 [TBL] [Abstract][Full Text] [Related]
32. Synergistic antitumor effects of human interferon-beta and interferon-gamma on human gastric adenocarcinoma cells. Nagao S; Nakano A; Moritake K; Morikawa S; Harada T Hum Cell; 1997 Mar; 10(1):95-104. PubMed ID: 9234070 [TBL] [Abstract][Full Text] [Related]
33. Stronger growth-inhibitory effect of interferon (IFN)-beta compared to IFN-alpha is mediated by IFN signaling pathway in hepatocellular carcinoma cells. Damdinsuren B; Nagano H; Wada H; Kondo M; Ota H; Nakamura M; Noda T; Natsag J; Yamamoto H; Doki Y; Umeshita K; Dono K; Nakamori S; Sakon M; Monden M Int J Oncol; 2007 Jan; 30(1):201-8. PubMed ID: 17143530 [TBL] [Abstract][Full Text] [Related]
34. Concomitant increases in galectin-1 and its glycoconjugate ligands (carcinoembryonic antigen, lamp-1, and lamp-2) in cultured human colon carcinoma cells by sodium butyrate. Ohannesian DW; Lotan D; Lotan R Cancer Res; 1994 Nov; 54(22):5992-6000. PubMed ID: 7954433 [TBL] [Abstract][Full Text] [Related]
35. Potentiation of butyrate-induced differentiation in human colon tumor cells by deoxycholate. Desai TK; Nathan DF; Morin MJ Cancer Lett; 1993 May; 69(3):181-6. PubMed ID: 8513444 [TBL] [Abstract][Full Text] [Related]
36. Differentiation of TERA-2 human embryonal carcinoma cells into neurons and HCMV permissive cells. Induction by agents other than retinoic acid. Andrews PW; Gönczöl E; Plotkin SA; Dignazio M; Oosterhuis JW Differentiation; 1986; 31(2):119-26. PubMed ID: 3017799 [TBL] [Abstract][Full Text] [Related]
37. Augmentation of antitumor activity of 5-fluorouracil by interferon alpha is associated with up-regulation of p27Kip1 in human hepatocellular carcinoma cells. Eguchi H; Nagano H; Yamamoto H; Miyamoto A; Kondo M; Dono K; Nakamori S; Umeshita K; Sakon M; Monden M Clin Cancer Res; 2000 Jul; 6(7):2881-90. PubMed ID: 10914738 [TBL] [Abstract][Full Text] [Related]
38. Interferon in combination with antitumourigenic phenyl derivatives: potentiation of IFN alpha activity in-vitro. Samid D; Yeh TJ; Shack S Br J Haematol; 1991 Oct; 79 Suppl 1():81-3. PubMed ID: 1931716 [TBL] [Abstract][Full Text] [Related]
39. Enhancement by stable butyrate derivatives of antitumor and antiviral actions of interferon. Pouillart P; Cerutti I; Ronco G; Villa P; Chany C Int J Cancer; 1992 Jun; 51(4):596-601. PubMed ID: 1318271 [TBL] [Abstract][Full Text] [Related]
40. Antiproliferative potencies of interferons on melanoma cell lines and xenografts: higher efficacy of interferon beta. Johns TG; Mackay IR; Callister KA; Hertzog PJ; Devenish RJ; Linnane AW J Natl Cancer Inst; 1992 Aug; 84(15):1185-90. PubMed ID: 1378904 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]